What is Kyntra Bio, Inc. (KYNB) stock price today?

Kyntra Bio, Inc. (KYNB) currently trades at $7.27 per share. The stock has a market capitalization of $28.37M and a P/E ratio of —x.

Is KYNB stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Kyntra Bio, Inc. has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Kyntra Bio, Inc.'s revenue and earnings?

Kyntra Bio, Inc. has trailing twelve-month (TTM) revenue of $6.44M with profit margins of 2,849.00%. Earnings per share (EPS) is $-14.40.

KYNB

Kyntra Bio, Inc.

NASDAQ: KYNB · HEALTHCARE · BIOTECHNOLOGY

$7.27

+3.12% today

Updated 2026-04-30

Market cap

$28.37M

P/E ratio

—

P/S ratio

4.41x

EPS (TTM)

$-14.40

Dividend yield

—

52W range

$5 – $13

Volume

0.0M

Market cap

$28.37M

P/E ratio

—

P/S ratio

4.41x

EPS (TTM)

$-14.40

Dividend yield

—

52W range

$5 – $13

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

5.0

Quality

C+

4.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$43.00

+491.47%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy1 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Profit margin 2,849.00% — above average

Risks

- Negative free cash flow $-18.33M

- Revenue declining -59.30% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$140.73M	$46.80M	$29.62M	$6.44M	$6.44M
Net income	$-293.65M	$-284.23M	$-47.58M	$183.45M	$-14.22M
EPS	—	—	—	—	$-14.40
Free cash flow	$-184.67M	$-317.54M	$-138.26M	$-4.81M	$-18.33M
Profit margin	-208.66%	-607.29%	-160.63%	2,848.63%	2,849.00%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
KYNB	$28.37M	26	2.7	4.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Kyntra Bio, Inc. trades at $7.27. Our Smart Value Score of 26/100 indicates the stock is weak. TTM revenue stands at $6.44M. with profit margins at 2,849.00%.

Frequently asked questions

What is Kyntra Bio, Inc.'s stock price?

Kyntra Bio, Inc. (KYNB) trades at $7.27.

Is Kyntra Bio, Inc. overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of Kyntra Bio, Inc. (KYNB)?

The analyst target price is $43.00, representing +491.5% upside from the current price of $7.27.

What is Kyntra Bio, Inc.'s revenue?

TTM revenue is $6.44M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio4.41x

ROE—

Beta0.90

50D MA$7.16

200D MA$8.96

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

KYNB vs LLY →KYNB vs JNJ →KYNB vs ABBV →Stock screener →